Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Cell Therapy Leverages Power of Regulatory T-Cells to Target Root Cause of Autoimmune Diseases with Dr. Mike McCullar RegCell TRANSCRIPT

Download PDF

Mar 19, 2026

Dr. Mike McCullar, CEO of RegCell, is developing a novel cell therapy to treat autoimmune diseases that specifically addresses the loss of tolerance, in which the immune system mistakenly attacks the body's own tissues. This approach contrasts with current treatments, which broadly suppress the immune system and may...

Cell Therapy Leverages Power of Regulatory T-Cells to Target Root Cause of Autoimmune Diseases with Dr. Mike McCullar RegCell

Mar 19, 2026

Developing Accessible Virus-Specific T-Cell Therapies to Treat Solid Tumors with Dr. Ivan Horak Tikva Allocell TRANSCRIPT

Download PDF

Mar 12, 2026

Dr. Ivan Horak, Founder and CEO of Tikva Allocell, is focused on next-generation allogeneic cell therapies using modified T-cells from healthy donors to make these therapies more scalable, accessible, and affordable. Using virus-specific T-cells, this approach is showing effectiveness against solid tumors, which...

Developing Accessible Virus-Specific T-Cell Therapies to Treat Solid Tumors with Dr. Ivan Horak Tikva Allocell

Mar 12, 2026

Next-Generation Stem Cell Therapy for Inflammation-Driven Degenerative Diseases with Ed Ahn MEDIPOST TRANSCRIPT

Download PDF

Mar 5, 2026

Ed Ahn, CEO of MEDIPOST, is developing next-generation stem cell therapies for inflammation-driven degenerative diseases with a primary focus on knee osteoarthritis. Using umbilical cord-derived stem cells, which have higher proliferation capacity than adult-derived stem cells, allows MEDIPOST to scale...